/PRNewswire/ ViCentra B.V., the company behind Kaleido, one of the world s smallest, lightest insulin patch pump systems for managing type 1 diabetes, is.
Current HFA-ESC guidelines for diuretics in acute heart failure led to significant increases in natriuresis and diuresis over 2 days compared with usual care, in ENACT-HF.